logo
  1. Home
  2. Stocks
  3. Kwality Pharmaceuticals

Kwality Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | BSE: 539997

₹677.85 image18.30 (2.77 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 669.90

High (₹) 687.00

Low (₹) 656.25

Prev. Close (₹) 659.55

Volume 6,649

VWAP (₹) 652.69

ROCE (%) 20.04

Industry P/E 43.95

TTM P/E 23.67

P/B Ratio 3.17

Market Cap (₹) Cr.703.35

Dividend Yield (%)--

EPS (₹) 22.76

ROE10.65%

Sales Growth (%) 22.36

Profit Growth (%)22.49

Day Range

687.00687.00

L
H

52 Week Range

405.001,069.95

L
H

Historical Returns

Returns (6M)

-12.55 %

Returns (1Y)

53.22 %

Returns (3Y)

75.93 %

Returns (5Y)

2159.5 %

Returns (6M)

-12.55 %

Returns (1Y)

53.22 %

Returns (3Y)

75.93 %

Returns (5Y)

2159.5 %

SWOT Analysis

  • Company with (25.33%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 25.33% positive TTM EPS growth
  • Growth in Net Profit Margin (QoQ)
  • Growth in Annual Net Profit with increasing Profit Margin (YoY)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 49.58

MFI 30.48

ATR 61.37

Commodity Channel Index -123.93

ROC125 -9.64

ROC21 -24.98

Williams %R -94.07

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current686.00719.15740.65664.50631.35609.85576.70
Week Ago719.36737.68747.36709.68691.36681.68663.36
Month Ago812.05832.70845.40799.35778.70766.00745.35

EMA & SMA
info_icon

677.85

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 691.82

9 Day 697.38

10 Day 710.70

12 Day 711.57

14 Day 723.84

20 Day 753.79

26 Day 775.37

50 Day 834.62

100 Day 840.88

200 Day 722.53

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell10 Jul, 2023₹316.411,37,152BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell03 Jul, 2023₹295.101,50,000BSE
BLUEPEAK CONSULTANCY LLPbulkBuy03 Jul, 2023₹295.0075,000BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell30 Jun, 2023₹295.381,04,000BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell26 Jun, 2023₹294.071,58,564BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell08 Jun, 2023₹295.491,00,000BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell05 Jun, 2023₹295.191,00,000BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell19 Jan, 2023₹344.242,50,000BSE
AKNM SUPPLIERS PRIVATE LIMITEDbulkSell16 Jan, 2023₹354.411,50,000BSE
DAR S BUSINESS FINANCE PVT LTDbulkSell01 Sept, 2022₹347.5080,155BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
17 Feb, 2024ADITYA ARORAAcquisition₹485.314,919BSE
04 Jul, 2023ADITYA ARORAAcquisition₹302.553,200BSE
30 Jun, 2023RAMESH ARORADisposal₹5,18,810BSE
30 Jun, 2023ADITYA ARORAAcquisition₹5,18,810BSE
29 Jun, 2022ADITYA ARORAAcquisition₹353.221,410BSE
24 Jun, 2022ADITYA ARORAAcquisition₹25,620BSE
24 Jun, 2022SACHIN SETHDisposal₹25,620BSE
26 Feb, 2022ADITYA ARORAAcquisition₹445.005,600BSE
25 Feb, 2022ADITYA ARORAAcquisition₹445.005,600BSE
16 Feb, 2022ADITYA ARORAAcquisition₹482.795,200BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
14 Feb, 2025BSE IndiaKwality Pharmaceuticals Limited receives product registrartion of Cyclophosphamide 1gm in Mexico
31 Jan, 2025BSE IndiaIntegrated filing (Financial) for the quarter and nine months ended December 31,2024 is enclosed
31 Jan, 2025BSE IndiaUNAUDITED FINANCIAL RESULTS FOR Q.E. 31-12-2024
31 Jan, 2025BSE IndiaPursuant to Regulation 30 & 33 read with clause 4 (h) of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulation, 2015 ('Listing Regulations'), this is to inform your that Board of Directors in its meeting held today i.e., January 31, 2025, have inter-alia, considered and approved the Unaudited Standalone and\r\nConsolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024, along with Limited Review Report issued by Statutory Auditors of the Company. A copy of the same is enclosed herewith.
21 Jan, 2025BSE IndiaKWALITY PHARMA RECEIVED SFDA APPROVAL FOR ITS GENERAL INJECTABLES AND BETA LACTAM (UNIT 1 & 2 IN AMRITSAR).
20 Jan, 2025BSE IndiaKwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine months ended December 31, 2024 along with Limited Review Report.
02 Jan, 2025BSE IndiaKwality Pharmaceuticals Limited receives RCGM Approval to Advance for Pre-Clinical Studies of Erythropoietin.
27 Nov, 2024BSE IndiaAnnouncement under Regulation 30(6) of SEBI (LODR) Regulations- Schedule of Analyst/ Investor Meeting
26 Nov, 2024BSE IndiaKwality received its first Biological Product Permission for Manufacturing and Sale of PEGylated - Asparaginase
06 Nov, 2024BSE IndiaKWALITY PHARMA RECEIVED THE APPROVAL FOR LEUPRORELIN ACETATE FOR INJECTABLE SUSPENSION AS A SITE VARIATION FROM GREECE.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--21 Jan, 202531 Jan, 2025
Quarterly Results--23 Oct, 202430 Oct, 2024
Quarterly Results--05 Aug, 202410 Aug, 2024
Audited Results--10 May, 202423 May, 2024
Quarterly Results--30 Jan, 202406 Feb, 2024
Quarterly Results--18 Oct, 202304 Nov, 2023
Quarterly Results--03 Aug, 202310 Aug, 2023
Audited Results--19 May, 202327 May, 2023
Quarterly Results--08 Feb, 202314 Feb, 2023
Quarterly Results--09 Nov, 202214 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Kwality Pharmaceuticals

Kwality Pharmaceuticals is a Public Limited Listed company incorporated on 04/05/1983 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1983PLC005426 and registration number is 005426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 307.17 Cr. and Equity Capital is Rs. 10.38 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1983

Managing Director

Mr. Ramesh Arora

NSE Symbol

--

Kwality Pharmaceuticals Management

NameDesignation
Mr. Ramesh AroraManaging Director
Mrs. Anju AroraWhole Time Director
Mrs. Geeta AroraWhole Time Director
Mr. Kiran Kumar VermaIndependent Director
Mr. Pankaj TakkarIndependent Director
Mr. Ravi Shanker SinghIndependent Director
Mr. Kartik KapurIndependent Director
Mr. Prashanth VellankiIndependent Director
Mr. Aditya AroraWholeTime Director & CFO
Mr. Ajay Kumar AroraWhole Time Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)		₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)		₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)		₹1,093.000 - ₹1,420.200

FAQs on Kwality Pharmaceuticals

What is the share price of Kwality Pharmaceuticals?

The share price of Kwality Pharmaceuticals on 13 Mar, 2025 is ₹ 677.85.

What is 52W high and 52W low share price of Kwality Pharmaceuticals?

The highest and lowest 52W share prices of Kwality Pharmaceuticals are ₹ 1069.950 and ₹ 405.000

What is the market cap of Kwality Pharmaceuticals?

The market capitalization of Kwality Pharmaceuticals as of 13 Mar, 2025 is ₹ 703.35 Crores

What is the P/E ratio of Kwality Pharmaceuticals?

The current P/E ratio of Kwality Pharmaceuticals as of 13 Mar, 2025 is 43.95

What is the PB ratio of Kwality Pharmaceuticals?

The PB ratio of Kwality Pharmaceuticals as of 13 Mar, 2025 is 3.17

Top Gainers

PASUSPG

Pasupati Spinning & Weaving Mills

₹41.02image

₹34.29 (0.20%)

OONE

ObjectOne Information Systems

₹8.84image

₹7.37 (0.20%)

JAINCO

Jainco Projects (India)

₹6.97image

₹5.81 (0.20%)

HITECHCORP

Hitech Corporation

₹194.70image

₹162.25 (0.20%)

Top Losers

MEHAI

Mehai Technology

₹13.75image

₹135.15 (-0.90%)

TRESCON

Trescon

₹9.60image

₹12.00 (-0.20%)

SAGL

Shalimar Agencies

₹9.80image

₹93.55 (-0.90%)

SHANGAR

Shangar Decor

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited